MAN & SCIENCE
- Industry
- Medical Equipment Manufacturing
- Founded Year
- 2012
- Headquarters
- Mont-Saint-Guibert, Belgium
- Employee Count
- 10
Key People
- Jean-Luc Boulanger - CEO
- Jean-Marc Boulanger - CTO
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises individuals with over a decade of experience in their respective fields.
The CEO and CTO have over 10 years of experience, providing a solid foundation for the company's strategic direction and technological development.
- Clinical Need
-
Aspect: Strong
Summary: There is a significant demand for effective headache treatments.
Headaches are a common ailment affecting a large portion of the population, indicating a strong clinical need for effective treatments.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players offering headache treatments.
While there are multiple companies providing headache treatments, innovative approaches can carve out a niche.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing effective neurostimulation therapies presents moderate technical challenges.
Creating neurostimulation devices requires overcoming certain technical challenges, but they are manageable with the right expertise.
- Patent
-
Aspect: Applied
Summary: The company has applied for patents to protect its innovations.
Applying for patents suggests the company is proactive in safeguarding its technological advancements.
- Financing
-
Aspect: Medium
Summary: The company has secured funding from regional investors.
While initial funding has been obtained, further investment will be necessary to expand and capture market share.
- Regulatory
-
Aspect: Running FIH
Summary: The company is conducting First-In-Human trials.
Engaging in First-In-Human trials is a critical step, but regulatory approval is still pending.
Opportunity Rollup
- Odds of Success
- 3.5
- Peak Market Share
- 4.85
- Segment CAGR
- 4.9%
- Market Segment
- Neurology Devices
- Market Sub Segment
- Neurostimulation Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.73 |
| 3 | 1.70 |
| 4 | 3.40 |
| 5 | 4.85 |
Key Takeaway
MAN & SCIENCE is well-positioned in the neurostimulation market for headache treatment, but must navigate competitive and regulatory challenges to achieve success.